ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 728512 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 728512; 2) Community: the network communities that were significantly associated with the response to NSC 728512; 3) Molecule: the relationships between components within communities and NSC 728512; 4) MDR: the compounds that were significantly associated with the NSC 728512.

NSC Compound Enrichment Correlation
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.00640068043275779 -0.036912295
NSC 717468 Null 0.00640068043275779 0.34326137
NSC 718781 Erlotinib hydrochloride 0.00640068043275779 -0.30584792
NSC 200692 Aspiculamycin hydrochloride 0.00648124190744032 -0.37379576
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.00648124190744032 0.22969912
NSC 650792 1,4,7,10-Tetrathia-13-azacyclopentadecane, 13-[(4-methylphenyl)sulfonyl]- 0.00648124190744032 -0.3070524
NSC 686368 Quinazolin-4(3H)-one, 3-ethyl- 2-[[[5-(phenylamino)-1,3,4-thiadiazol-2-yl]methyl]thio]- 0.00648124190744032 -0.28266824
NSC 702129 Null 0.00648124190744032 -0.29252016
NSC 709928 Null 0.00648124190744032 -0.23448304
NSC 741738 1-(7-Methoxy-3-methyl-1,4-dioxy-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.00648124190744032 -0.11384792
Total:139  Current:29    [First] [Prev] [Next] [Last]